医学
血流感染
导管
菌血症
重症监护医学
放射科
微生物学
抗生素
生物
作者
Claudia Torres‐Farfan,Mark E. Rupp,Kelly Cawcutt
标识
DOI:10.1016/j.idc.2024.07.002
摘要
Hospital-acquired infections, including central line associated bloodstream infections (CLABSI), are an ongoing source of cost, morbidity, and mortality worldwide. This article presents a summary of the impact of the recent SARS-CoV-2 pandemic on CLABSI incidence, an overview of current standard-of-care practices for reduction of CLABSI, and a look toward future changes in bacteremia metrics and challenges in prevention.
科研通智能强力驱动
Strongly Powered by AbleSci AI